Leonabio, Inc. · NASDAQ:LONA
Anders Hove reported a 5.20% stake in Leonabio, Inc. (Schedule 13G)
Event Dec 22, 2025 · Filed Dec 23, 2025
Anders Hove reported a 5.20% stake in Leonabio, Inc., 501,739 shares, as a passive investor on Dec 22, 2025. Filed Dec 23, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 501,739
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ACORN BIOVENTURES, L.P. | 2.20% | 210,730 |
| ACORN CAPITAL ADVISORS GP, LLC | 2.20% | 210,730 |
| ACORN BIOVENTURES 2, L.P. | 3.00% | 291,009 |
| Acorn Capital Advisors GP 2, LLC | 3.00% | 291,009 |
| Anders Hove | 5.20% | 501,739 |
Source
Related
- Leonabio, Inc.
- Anders Hove
- Leonabio, Inc. shareholders
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G/A · Anders Hove · Jan 8, 2026
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026